Povidone-iodine reduces contamination rate

Article

A recent prospective study has shown that the repetitive irrigation of povidone-iodine of 0.25% significantly lowered bacterial contamination rate in the anterior chamber after cataract surgery.

A recent prospective study has shown that the repetitive irrigation of povidone-iodine of 0.25% significantly lowered bacterial contamination rate in the anterior chamber after cataract surgery.

Dr Hiroyuki Shimada and Dr Takayuki Hattori, Department of Ophthalmology, School of Medicine, Nihon University, Tokyo, Japan, investigated the use of povidone-iodine to reduce bacteria in patients with cataracts.

The investigation involved 404 consecutive eyes - 202 eyes were filled with infusion liquid (group A) and 202 eyes were treated using povidone-iodine of 0.25%. The fluids from the anterior chamber were collected at the start and end of surgery to measure the iodide ion concentration. Bacteriologic culture was carried out using the ocular surface fluid after lid speculum placement, and anterior chamber fluid after surgery. The measurement of corneal endothelial cell density was conducted before and after surgery, using a specular microscope.

The rate of bacterial detection in ocular surface liquid demonstrated a small difference between groups A (5.5%) and B (6.0%). However, the reduction rate in anterior chamber fluid was significantly greater in group B.

To conclude, the repetitive irrigation of the anterior chamber lowered bacterial contamination to a great extent after cataract surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.